Your browser doesn't support javascript.
loading
Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
Yin, Wan-Jun; Wang, Peng; Ma, Shuang-Shuang; Tao, Rui-Xue; Hu, Hong-Lin; Jiang, Xiao-Min; Zhang, Ying; Tao, Fang-Biao; Zhu, Peng.
Afiliação
  • Yin WJ; Joint Research Center of Occupational Medicine and Health, Institute of Grand Health, Hefei Comprehensive National Science Center, Anhui University of Science and Technology, Hefei, China.
  • Wang P; School of public health, Anhui University of Science and Technology, Hefei, China.
  • Ma SS; Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University, Hefei, China.
  • Tao RX; MOE Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Hefei, 230032, China.
  • Hu HL; Key Laboratory of Industrial Dust Prevention and Control, Occupational Safety and Health, Ministry of Education, Anhui University of Science and Technology, Hefei, China.
  • Jiang XM; Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University, Hefei, China.
  • Zhang Y; MOE Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Hefei, 230032, China.
  • Tao FB; Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University, Hefei, China.
  • Zhu P; MOE Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Hefei, 230032, China.
Eur J Nutr ; 2024 Jun 15.
Article em En | MEDLINE | ID: mdl-38878202
ABSTRACT

PURPOSE:

Women with gestational diabetes mellitus (GDM) or obesity are vulnerable to impaired gestational cardiovascular health (CVH) and cardiovascular disease (CVD) in the future. It is unclear if prenatal vitamin D supplementation improves gestational CVH, especially in women at high risk for developing CVD. Our goal was to find out if vitamin D supplementation could protect against gestational CVH, including the women with GDM or obesity.

DESIGN:

We randomly assigned women with a serum 25(OH)D concentration < 75 nmol/L to receive 1600 IU/d (intervention group) or 400 IU/d (control group) of vitamin D3 for two months at 24-28 weeks' gestation. The primary outcome was gestational CVH marks (lipids, inflammatory cytokines, endothelial function).

RESULTS:

There were 1537 participants divided into the intervention (N = 766) and control groups (N = 771). No baseline differences existed among study groups in CVH markers. At the two-month visit, the intervention group's HDL-C levels (2.01 ± 0.39 VS 1.96 ± 0.39 mmol/L) were significantly higher than those of the control group, while the hs-CRP levels were significantly lower (3.28 ± 2.02 VS 3.64 ± 2.42 mg/L). Subgroup analysis found that HDL-C, TC, hs-CRP, E-Selectin, and SBP were improved in the intervention group among women with GDM or overweight/obesity, and the improvement was not found in women without GDM or overweight/obesity. Vitamin D supplementation significantly decreased the mean triglyceride-glucose index at the two-month visit in women with GDM.

CONCLUSIONS:

Vitamin D supplementation at mid-gestation might optimize the gestational CVH status for pregnant women, particularly the women with GDM or obesity, which is advantageous for later-life primary prevention of CVD. CLINICAL TRIAL REGISTRATION The Chinese Clinical Trial Registry (ChiCTR2100051914, 10/9/2021, Prospective registered, https//www.chictr.org.cn/showproj.aspx?proj=134700 ).
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Nutr Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Nutr Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China